1. Search Result
Search Result
Targets Recommended: CRISPR/Cas9
Results for "

916138-87-9

" in MCE Product Catalog:
Cat. No. Product Name Target Research Areas
  • HY-P99023
    Girentuximab

    G250; cG250

    Carbonic Anhydrase Cancer
    Girentuximab (G250) is a chimeric monoclonal antibody that binds carbonic anhydrase IX (CAIX), a cell surface glycoprotein ubiquitously expressed in clear cell renal cell carcinoma (ccRCC).